ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02545283
Brief Title: A Study of Idasanutlin With Cytarabine Versus Cytarabine Plus Placebo in Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML) (MIRROS)

First Submitted : August 31, 2015
First Submitted that Met QC Criteria : September 8, 2015
First Posted : September 9, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : February 8, 2019
Last Update Posted : February 11, 2019